Mezlocillin
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl- 2-oxo-imidazolidine-1-carbonyl)amino]-2-phenyl-acetyl] amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2- carboxylic acid |
|
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy cat. | B |
| Legal status | ? |
| Routes | Intravenous, intramuscular |
| Pharmacokinetic data | |
| Protein binding | 16–59% |
| Metabolism | Hepatic (20–30%) |
| Half-life | 1.3–4.4 hours |
| Excretion | Renal (50%) and biliary |
| Identifiers | |
| CAS number | 51481-65-3 |
| ATC code | J01CA10 |
| PubChem | CID 656511 |
| DrugBank | DB00948 |
| ChemSpider | 570894 |
| UNII | OH2O403D1G |
| KEGG | D05021 |
| ChEBI | CHEBI:6919 |
| ChEMBL | CHEMBL1731 |
| Chemical data | |
| Formula | C21H25N5O8S2 |
| Mol. mass | 539.584 g/mol |
|
|
|
|
| |
|
Mezlocillin is a broad-spectrum penicillin antibiotic. It is active against both Gram-negative and some Gram-positive bacteria. Unlike most other extended spectrum penicillins, it is excreted by the liver, therefore it is useful for biliary tract infections, such as ascending colangitis.
Contents |
Mechanism of action [edit]
Main article: Beta-lactam antibiotic
Like all other beta-lactam antibiotics, mezlocillin inhibits the third and last stage of bacterial cell wall synthesis by binding to penicillin binding proteins. This ultimately leads to cell lysis.
Susceptible organisms [edit]
Gram-negative [edit]
- Bacteroides spp., including B. fragilis
- Enterobacter spp.
- Escherichia coli
- Haemophilus influenzae
- Klebsiella species
- Morganella morganii
- Neisseria gonorrhoeae
- Proteus mirabilis
- Proteus vulgaris
- Providencia rettgeri
- Pseudomonas spp., including P. aeruginosa
- Serratia marcescens
Gram-positive [edit]
External links [edit]
- DDB 30377
- -288358398 at GPnotebook
- Duke
- Kristof R, Clusmann H, Koehler W, Fink K, Schramm J (1998). "Treatment of accidental high dose intraventricular mezlocillin application by cerebrospinal fluid exchange.". J Neurol Neurosurg Psychiatry 64 (3): 379–81. doi:10.1136/jnnp.64.3.379. PMC 2170014. PMID 9527154.
- McCormick P, Greenslade L, Kibbler C, Chin J, Burroughs A, McIntyre N (1997). "A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients.". Hepatology 25 (4): 833–6. doi:10.1002/hep.510250408. PMID 9096584.
- Rohde B, Werner U, Hickstein H, Ehmcke H, Drewelow B (1997). "Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure.". Eur J Clin Pharmacol 53 (2): 111–5. doi:10.1007/s002280050347. PMID 9403281.
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||